Q4 2024 scPharmaceuticals Inc Earnings Call
Good afternoon, and welcome to scPharmaceuticals fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now ...
scPharmaceuticals price target lowered to $12 from $20 at Maxim
Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after ...
Craig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)
In a report released today, Chase Knickerbocker from Craig-Hallum reiterated a Buy rating on scPharmaceuticals (SCPH – Research Report). The ...